Dysbiosis
& the Aging Gut
Your gut hosts 38 trillion microorganisms — more than your own cells. By age 70, microbial diversity drops ~30%, SCFA production collapses, and gut permeability rises, flooding the body with bacterial endotoxins that drive systemic inflammation.
The Mechanism
The gut-inflammaging axis — three failure cascades
Aging microbiome shifts follow a predictable pattern: Faecalibacterium prausnitzii (the primary butyrate producer and anti-inflammatory organism) and Bifidobacterium (short-chain fatty acid producer, barrier maintainer) decline. Proteobacteria (gram-negative LPS-rich bacteria) expand. The result: less butyrate to fuel colonocytes, more LPS to trigger systemic TLR4 activation.
Leaky gut follows: tight junction proteins (ZO-1, occludin) require butyrate for expression. As SCFA production falls, tight junctions weaken. Bacterial LPS and peptidoglycans translocate into portal circulation — driving hepatic NF-κB activation, systemic IL-6 production, and metabolic endotoxemia.
The gut also produces ~90% of systemic serotonin and hosts the enteric nervous system — 500 million neurons communicating bidirectionally with the brain via the vagus nerve. Dysbiosis disrupts gut-brain axis signaling, driving neuroinflammation, altered mood, and impaired cognitive function independently of systemic cytokine effects.
The microbiome also regulates NAD+ metabolism via the kynurenine pathway. Age-related dysbiosis shifts tryptophan metabolism away from serotonin/NAD+ production toward inflammatory kynurenines — reducing NAD+ precursor availability and amplifying neuroinflammation simultaneously.
Monitoring
Gut health biomarkers
Evidence-Graded Interventions
Microbiome restoration with clinical evidence
Tier A = human RCT evidence. Tier B = at least one human trial + mechanistic data.
Diverse Plant Fiber (30+ species/week)
Tier AThe most evidence-backed microbiome intervention. Diverse fiber feeds SCFA-producing taxa (Faecalibacterium prausnitzii, Roseburia, Bifidobacterium) that ferment fiber to butyrate, propionate, and acetate. Butyrate is the primary fuel for colonocytes, the main HDAC inhibitor in the gut, and a direct inducer of colonic regulatory T-cells (suppressing intestinal inflammation). APC guidelines recommend 30+ species/week.
Fermented Foods Daily
Tier AThe landmark 2021 Sonnenburg/Gardner Stanford trial (PMID: 34432955) compared high-fiber vs high-fermented food diets in adults for 17 weeks. Fermented food increased microbiome diversity, reduced 19 inflammatory markers including IL-6 and IL-12, and expanded novel bacterial strains. The fiber arm showed no diversity increase — fermented foods outperformed.
Sulforaphane (Gut NRF2 / Barrier)
Tier BNRF2 is highly expressed in gut epithelial cells. Sulforaphane activates NRF2 in colonocytes and enterocytes, upregulating tight junction proteins (ZO-1, claudin-3) and reducing epithelial ROS — the primary driver of gut barrier permeability. Also selectively favors Lactobacillus/Bifidobacterium over pro-inflammatory species in preclinical models.
Targeted Probiotics (Akkermansia, Bifidobacterium)
Tier BAkkermansia muciniphila — the gut barrier guardian — declines from 4% in young adults to near 0% in the elderly. A 2019 Belgian RCT (PMID: 31792544) showed pasteurized Akkermansia improved insulin sensitivity, reduced liver inflammation markers, and decreased gut permeability in overweight adults. Bifidobacterium longum reduces anxiety-linked cortisol and IL-6.
Rebuild your microbiome.
30 plant species a week + daily fermented foods is the highest-ROI gut intervention. Sulforaphane protects the barrier. Track zonulin in the Labs.